March 29th 2023
Among persons with prediabetes who reverted to normoglycemia, only those who remained physically active saw a reduced risk of all-cause death, study authors report.
March 28th 2023
A new study examines the legacy effects of weight loss on cardiometabolic disease risk factors, finding benefits persist up to 5 years, despite weight regain.
March 27th 2023
The disproportionate prevalence of undiagnosed diabetes among racial/ethnic minorities in the US begs for a new screening paradigm; this may be the one.
March 20th 2023
Sanofi is the third key insulin maker to announce reductions in the cost of its products, joining other giants Eli Lilly and Co and Novo Nordisk.
March 17th 2023
The announcement follows by 2 weeks a similar plan from Eli Lilly to reduce patient costs as the Biden administration touts effects of new laws on drug prices.
Patients with Diabetes Face Higher Risk for Left-sided Valvular Stenotic Lesions
A new study found patients with T1D and T2D had a greater risk for stenotic lesions, whereas risk for valvular regurgitation was lower in those with T2D.
Study: AI-powered Intervention Led to Highest Reported Rate of T2D Remission to Date
ADA 2022: Patients with T2D who received a treatment intervention powered by artificial intelligence achieved a remission rate of more than 80%.
Dulaglutide Improves HbA1c for Youth with Type 2 Diabetes without Change in BMI
ADA 2022: "Breakthrough" findings may help to address the unmet need for additional treatment options for young patients with type 2 diabetes.
Younger Age and Higher HbA1c Among Factors Linked to CGM Uptake in New Study
ADA 2022: Younger age, insulin use, higher HbA1c, and higher diabetes distress were found to be associated with CGM uptake in prospective study.
Patients with Diabetes Up to 4-times More Likely to Develop Long COVID-19
ADA 2022: In a new literature review, 43% of studies included identified diabetes as a potent risk for developing post-acute sequelae of COVID-19.
Tirzepatide Treatment Leads to Weight Loss of up to 22.5% in SURMOUNT-1 Clinical Trial
ADA 2022: Tirzepatide led overall to weight loss of up to 22.5% of baseline body weight with persons taking the 15 mg dose losing an average of 52 pounds.
Tailored Diabetes Risk Assessment May Reduce Racial/Ethnic Disparities in Diagnosis
Lowering thresholds for BMI value and age of first diabetes screening among large US minority populations could greatly increase rates of diagnosis and improve care.
Prototype of “Multi-tasking” Wearable Found to Continuously Monitor Glucose, Alcohol, and Lactate Levels
The wearable device allows users to monitor their health while also performing their regular daily activities.
Latest Advances in CGM Technology: A 5-question Quiz
SAMPLE: What was the first FDA-approved CGM system to include a fully implantable sensor to detect glucose?
SGLT-2 Inhibitor and GLP-1 Receptor Agonist Prescribing Trends 2015-2020
PCPs and internists accounted nationally for 57% of SGLT2i and 52% of GLP1RA prescriptions in 2020, more than any other specialty, according to new research.
Novel Once-Weekly Insulin Icodec Found Superior vs Insulin Degludec in Reducing HbA1c in Type 2 Diabetes
The ONWARDS 2 trial achieved its primary endpoint of demonstrating non-inferiority in reducing HbA1c at week 26 with insulin icodec vs insulin degludec.
Newly Developed Polygenic Risk Scores May Assist Decision-making in Primary Care
Researchers developed polygenic risk scores for 6 common diseases and informational resources to help primary care physicians incorporate them into clinical practice.
Finerenone Consistently Reduced Cardiorenal Risk Regardless of ASCVD History in FIDELITY
In patients with type 2 diabetes and chronic kidney disease with and without history of CVD, finerenone was associated with improved CV and kidney outcomes.
New Diabetes Device Comparison Platform Supports Clinical Decision-making, Prescribing
DiabetesWise Pro, created at Stanford University, provides an unbranded, unbiased guide to matching diabetes technology to patient needs, access, and lifestyle.
Diabetes Technology Myths & Facts for Primary Care Practitioners
Initiating diabetes technology of any kind is a big step for patients, but also for a lot of primary care clinicians. If you have concerns, these myths and facts are for you.
Moderate Wine Intake with Food May Help Decrease T2D Risk in Adults
Moderate consumption of alcohol with food was significantly associated with a 14% lower risk of type 2 diabetes in a preliminary analysis.
FDA Grants Clearance to First Smartphone App for Programming Insulin Dosing
t:slim X2 insulin pump users can now program or cancel bolus dosing with the secure t:connect mobile app already on their phones, says Tandem Diabetes Care.
NOACs Linked to Lower Risk for Vascular Issues than Warfarin in Patients with Diabetes, Atrial Fibrillation
Researchers in Taiwan found NOACs were associated with lower hazards of diabetes complications. and death than warfarin in persons with AF and DM.
FDA Approves Eversense E3 CGM System for Use up to 6 Months
The 180-day sensor life doubles the period of continuous use and cuts in half the number of CGM removals and reinsertions, without loss of accuracy.
Blood Glucose Levels in T2D: 42 Factors that Make A Difference
These 42 factors that affect blood glucose are listed in categories including food, activity, and biological influences. Perfect information to share with your patients with T2D.
Tirzepatide Found Safe, Effective as Add-on to Stable Basal Insulin in T2D Patients Not at Goal
Tirzepatide at 3 different doses significantly improved glycemic control and promoted weight loss when added to titrated insulin in patients with type 2 diabetes.
Painful Diabetic Neuropathy Treatment: A Guideline Topline
The American Academy of Neurology recently issued a guideline on oral and topical treatments for painful diabetic neuropathy. Here, a concise summary for clinicians.
Blood Glucose Down, Insulin Sensitivity Up with 10 Minutes of Moderate-intensity Stair Stepping
Glucose and insulin levels decreased after just 3 minutes of the moderate-intensity exercise, a promising finding for those with type 2 diabetes, say authors of a new study.
Less than 1 in 5 US Adults Meeting Heart Health Goals, According to AHA Scientific Statement
Available therapies combined with new approaches that address social determinants of health and other barriers to care can help, suggests new statement.
American Diabetes Association Publishes Standards of Medical Care for 2022
The ADA's annual update to its comprehensive evidence-based standards includes new guidance on diabetes screening, first-line therapies, and comorbid NAFLD/NASH.
Current Advances in Continuous Glucose Monitoring Technology
CGMs have revolutionized diabetes management for patients and healthcare providers alike. This slide show summarizes the most recent enhancements.
12 Drugs Approved for Primary Care in 2021
Get a quick look at 12 of the many FDA-approved drugs in 2021 for conditions commonly seen in primary care.
DIABETES: 2021 Clinical Focus Collection
ADA 2021 Scientific Sessions recap, tests of clinical knowledge, expert interviews, and more in this roundup from Patient Care Online.
In Adults with T2D, Low-energy Diets with Meal Replacement Most Effective for Weight Loss, Remission
Weight loss and disease remission in T2D may differ between patients regardless of type of diet regimen chosen, say authors of a new analysis.
Statin Use Associated with Diabetes Progression, Suggests New Retrospective Cohort Study
Among patients with diabetes, over 50% of statin users experienced diabetes progression vs 48% of non-statin users, according to a retrospective matched-cohort study.
2 Clarke Drive Cranbury, NJ 08512